Our patients did not show clinically detectable neuropathy, but future studies should include quantitative sensory testing to provide information about pre-clinical neuropathy, especially in obese subjects with altered quantitative insulin-sensitivity check index (QUICKI). The gene discussed is INS; the disease is neuropathy.